Program Overview
Designed to complement the HFSA Board Certification Review Course OnDemand, the HFSA Contemporary Issues in Heart Failure educational bundle delivers a well-rounded and practical learning experience for clinicians managing patients with heart failure.
While the Board Review Course focuses on foundational knowledge for certification preparation, HFSA Contemporary Issues in Heart Failure centers on real-world clinical challenges—the nuanced and often complex scenarios that clinicians encounter in daily practice. This bundle includes 11 expert-led presentations, each approximately 30 minutes in length, exploring evolving concepts, novel therapies, and clinical decision-making strategies in advanced heart failure and transplantation.
Learning Highlights
- Eleven high-impact presentations (30 minutes each)
- Focused on practical, case-based insights rather than exam preparation
- Curated by leading experts in advanced heart failure and transplantation
- Designed to enhance day-to-day clinical decision-making
Target Audience
This activity is intended for trainees, fellows, physicians, advance practice providers, nurses, pharmacists and pharmacologists, and other health care providers who care for patients with heart failure.
Faculty
what about the planning committee?
- Ben Bryner, MD
- Jennifer Cowger, MD, MS
- Manreet Kanwar, MD
- Michelle Kittleson, MD
- Kiran K. Kush, MD, MAS
- Andrew Rosenbaum, MD
- Palak Shah, MD, MS, FHFSA
- Shashank Sinha
- Jeffrey Testani, MD, MTR
- Sean Pinney, MD, MS, FHFSA
Presentations
Non-Invasive Methods for Diagnosing Rejection after Heart Transplantation
Kiran K. Kush, MD, MAS
Diagnosis and Treatment of Inflammatory Cardiomyopathies
Andrew Rosenbaum, MD
Donor Heart Selection
Palak Shah, MD, MS, FHFSA
Approach to Antibodies in Heart Transplantation
Michelle Kittleson, MD
Expanding Heart Transplantation - Methods of Heart Procurement and Preservation
Ben Bryner, MD
Management of Fluid Overload and Renal Dysfunction in Advanced HF – Part 1
Jeffrey Testani, MD, MTR
Management of Fluid Overload and Renal Dysfunction in Advanced HF – Part 2
Jeffrey Testani, MD, MTR
Desensitization Strategies
Sean Pinney, MD, MS, FHFSA
Understanding UNOS/OPTN and HRSA
Jennifer Cowger, MD, MS
Content Coming Soon!
Device Selection in STEMI and Non-STEMI Shock
Faculty Disclosure
The Heart Failure Society of America (HFSA) is committed to ensuring balance, independ-ence, objectivity, and scientific rigor in its educational activities. HFSA has a disclosure policy that requires oral presenters to disclose all relevant financial relationships for themselves and their spouse or partner during the past 24-months with any commercial entity producing, marketing, re-selling, or distributing health care goods or services con-sumed by, or used on patients and related to the content of the activity, whether or not these commercial entities are supporters of the activity.
Speakers will have a disclosure slide at the beginning of each presentation. All potential conflicts of interests have been resolved in accordance with the ACCME Updated Stand-ards for Commercial Support.
The following faculty and/or accreditors with ability to control content for this activity have no conflict of interest:
• Michelle Kittleson, MD
The following faculty and/or accreditors with ability to control content for this activity have listed the below disclosures:
• Jennifer Cowger, MD, MS
• Manreet Kanwar, MD
• Kiran K. Kush, MD, MAS
• Sean Pinney, MD, MS, FHFSA
• Andrew Rosenbaum, MD
• Palak Shah, MD, MS, FHFSA
• Shashank Sinha, MD, MSc, FHFSA
• Nancy Sweitzer, MD, PhD, FACC, FAHA, FHFSA
Off-Label Disclosure
This CME activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products dis-cussed. The information provided in this CME activity is for continuing medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options for a specific patient’s medical condition.
Continuing Education Statement
In support of improving patient care, The Heart Failure Society of America is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The Heart Failure Society of America designates this live activity for a maximum of 5.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This educational activity is approved for nursing continuing professional development (NCPD) units by the Heart Failure Society of America. This activity is approved for a maximum of 5.50 contact hours.
The Heart Failure Society of America is an accredited provider of continuing pharmacy education (CPE). This event is accredited for up to 5.50 contact hours of knowledge-based CPE. ACPE Universal Activity Numbers (UAN): JA4008267-0000-25-013-H01-P.
The Heart Failure Society of America has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 5.50 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
This activity is approved for 5.50 contact hours (0.55 CEUs) of general continuing education for health care professionals.
Learners can claim only the credit hours of the completed sessions listed below. This denotes their participation in the activity.
Successful completion of this activity includes the completion of the post-course evaluation.
Supporters
No current grants/supporters.